The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet®/ Dovobet®) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial
✍ Scribed by P.C.M. Van De Kerkhof
- Book ID
- 108667703
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 114 KB
- Volume
- 151
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Calcipotriol and betamethasone dipropionate are both widely used, effective treatments for psoriasis. vitamin d analogues and topical corticosteroids have different mechanisms of action in the treatment of psoriasis. a new vehicle has been developed in order to contain both calcipotr
## Background: Botulinum toxin type a (btx-a) has been shown to be a safe and effective treatment for primary focal hyperhidrosis. however, the effect of btx-a therapy on quality of life (qol) in patients with this condition has only recently begun to be studied in controlled clinical trials. ## O